Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-2002 | 07-2002 | 04-2002 | 01-2002 | 10-2001 | |
| Sales | 382 | 0 | 547 | 797 | 410 |
| Cost of Goods | 740 | N/A | 542 | 594 | 452 |
| Gross Profit | -358 | N/A | 5 | 203 | -42 |
| Operating Expenses | 1,199 | 0 | 1,565 | 1,444 | 1,494 |
| Operating Income | -817 | N/A | -1,017 | -647 | -1,084 |
| Other Income | 1,596 | 0 | -15 | -520 | 45 |
| Pre-tax Income | 779 | 0 | -1,032 | -1,167 | -1,039 |
| Net Income Continuous | 779 | N/A | -1,032 | -1,194 | -1,039 |
| Net Income | $779 | $N/A | $-1,032 | $-1,194 | $-1,039 |
| EPS Basic Total Ops | 0.13 | N/A | -0.17 | -0.19 | -0.17 |
| EPS Basic Continuous Ops | 0.13 | N/A | -0.17 | -0.19 | -0.17 |
| EPS Diluted Total Ops | 0.13 | N/A | -0.17 | -0.19 | -0.17 |
| EPS Diluted Continuous Ops | 0.13 | N/A | -0.17 | -0.19 | -0.17 |
| EBITDA(a) | $-714 | $N/A | $-969 | $-544 | $-1,032 |